Study of Enzastaurin Versus Placebo With Pemetrexed for Patients With Advanced or Metastatic Lung Cancer

Mise à jour : Il y a 4 ans
Référence : NCT00530621

Femme et Homme

Extrait

The purpose of this study is to determine if the combination of enzastaurin and pemetrexed can extend survival time without progression of disease for patients who have advanced or metastatic non-small cell lung cancer.


Critère d'inclusion

  • non-small cell lung cancer


Liens